ENDOVASC, INC. 8-K 08-18-2005
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 16, 2005
ENDOVASC, INC.
(Exact Name of Small Registrant as Specified in Its Charter)
NEVADA
(State or Other Jurisdiction of Incorporation)
000-28371 76-0512500
(Commission File Number) (IRS Employer Identification No.)
550 CLUB DRIVE, SUITE 440
MONTGOMERY, TEXAS 77316
(Address of Principal Executive Offices) (Zip Code)
(936) 582-5920
(Registrant's Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act
[_] Soliciting material pursuant to Rule 14a-12 under the Securities Act
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act
[_] Pre commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act
SECTION 4 - MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL STATEMENTS
ITEM 4.01. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
Endovasc, Inc., announced today that the Company has retained McConnell &
Jones LLP as its registered independent accountants to perform the Company's
annual and financial control audits, including quarterly reports.
McConnell & Jones LLP is a certified public accounting firm based in Houston,
TX. The experienced team at McConnell & Jones LLP serves a diverse section of
businesses, state and local government agencies, and nonprofit organizations
through a combination of assurance services that includes audits, review
examinations and compilations.
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
The following documents are filed as an exhibit to this report.
EXHIBIT DESCRIPTION
- ------- -----------------------------------------------------
16.1* Endovasc press release dated August 16, 2005
ENDOVASC, INC.
(Registrant)
Date: August 18, 2005 /s/ Diane Dottavio
By: ------------------------------
(Signature)
Name: Diane Dottavio
Title: President and Chief Executive Officer